Review
Published on 23 May 2024
Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1408636
- 2,750 views
- Frontiers in Medicine
- Regulatory Science
- Articles
Type at least 3 characters
384 articles
Articles
Mini Review
Published on 22 May 2024
Artificial intelligence in drug repurposing for rare diseases: a mini-review
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1404338
- 3,481 views
Methods
Published on 16 May 2024
OHDSI-compliance: a set of document templates facilitating the implementation and operation of a software stack for real-world evidence generation
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1378866
- 929 views
Original Research
Published on 15 May 2024
Artificial intelligence based data curation: enabling a patient-centric European health data space
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1365501
- 3,049 views
Mini Review
Published on 13 May 2024
Exploring regulatory flexibility to create novel incentives to optimize drug discovery
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1379966
- 1,178 views
- 1 citation
Policy and Practice Reviews
Published on 09 May 2024
Cybersecurity policy framework requirements for the establishment of highly interoperable and interconnected health data spaces
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1379852
- 1,367 views
Methods
Published on 02 May 2024
Application of the Composite Quality Score (CQS-2B) versus Cochrane’s Risk of Bias tool (Version 2) in systematic reviews of clinical trials – an exploratory study
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1307815
- 537 views
Brief Research Report
Published on 26 Apr 2024
Promoting opioids, a story about how to influence medical science and opinions
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1327939
- 1,742 views
- 2 citations
Original Research
Published on 17 Apr 2024
The creation of an adaptable informed consent form for research purposes to overcome national and institutional bottlenecks in ethics review: experience from rare disease registries
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1384026
- 1,035 views
Mini Review
Published on 12 Apr 2024
Synthetic polypeptides using a biologic as a reference medicinal product – the European landscape of regulatory approvals
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1335928
- 1,806 views
Perspective
Published on 11 Apr 2024
Perspectives on systematic capacity building in pharmaceutical regulation for regulators of medical products
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1394562
- 1,150 views
Original Research
Published on 10 Apr 2024
Health data space nodes for privacy-preserving linkage of medical data to support collaborative secondary analyses
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1301660
- 2,409 views
Original Research
Published on 05 Apr 2024
Identifying and costing common gaps in Central and West Africa pharmaceutical regulation
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1362253
- 2,651 views
- 1 citation
Policy Brief
Published on 02 Apr 2024
Declaration of Helsinki: ethical norm in pursuit of common global goals
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1360653
- 3,371 views
- 5 citations
Original Research
Published on 28 Mar 2024
Innovative research methodologies in the EU regulatory framework: an analysis of EMA qualification procedures from a pediatric perspective
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1369547
- 2,229 views
- 1 citation
Hypothesis and Theory
Published on 28 Mar 2024
Physician’s autonomy in the face of AI support: walking the ethical tightrope
in Regulatory Science
Frontiers in Medicine
doi 10.3389/fmed.2024.1324963
- 1,571 views
- 1 citation